ScholarLens Back to search
2006•Unpublished venueRequires access

Vaccines for the Prevention of Human Papillomavirus Infections

Stuart Maddin, Hugo J. Degreef, Jason Keller Rivers, Jeffrey S. Dover, Murad Alam, Kenneth A. Arndt, Wilma Fowler Bergfeld, Jan Dositheus Bos, ALASTAIR J. CARRUTHERS, Bryce Cowan, Boni Elizabeth Elewski

Open publisher page 0 citations

Abstract

Human papillomavirus (HPV) infection is the known cause of almost all cases of cervical cancer. An understanding of the HPV genome has allowed the development of two prophylactic vaccines capable of protecting against both persistent HPV infection and cervical intraepithelial neoplasia (CIN) with 100% efficacy in fully vaccinated women. The vaccines, manufactured by Merck (Gardasil ® , which was approved by

About this research paper

What this paper is about

Human papillomavirus (HPV) infection is the known cause of almost all cases of cervical cancer. An understanding of the HPV genome has allowed the development of two prophylactic vaccines capable of protecting against both persistent HPV infection and cervical intraepithelial neoplasia (CIN) with 100% efficacy in fully vaccinated women. The vaccines, manufactured by Merck (Gardasil ® , which was approved by

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Human papillomavirus (HPV) infection is the known cause of almost all cases of cervical cancer. An understanding of the HPV genome has allowed the development of two prophylactic vaccines capable of protecting against both persistent HPV infection and cervical intraepithelial neoplasia (CIN) with 100% efficacy in fully vaccinated women. The vaccines, manufactured by Merck (Gardasil ® , which was approved by

Key concepts: Gardasil, HPV vaccines, Human papillomavirus, Cervical intraepithelial neoplasia, Cervical cancer, Medicine, Virology, Human papillomavirus vaccine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Vaccines for the Prevention of Human Papillomavirus Infections — Research Paper | ScholarLens